Skip to main content
. 2022 Mar 21;187(2-3):271–289. doi: 10.1007/s11046-022-00627-8

Table 1.

Study and patients characteristics

Author Country Design Setting Confirmed CAM, N Observational period Age (Mean, SD) [range] Male, % (N) Diabetes, % (N)
Moorthy A. [20] India Retrospective Multi-center 17 May 2020–Dec 2020 55 [35–73] 83 (14) 88 (15)
El-Kholy NA. [21] Egypt Prospective Single-center 28 Aug 2020–Dec 2020 53 ± 11 53 (15)
Ravani SA. [22] India Retrospective Single-center 31 Sep 2020–Mar 2021 56 65 (20) 94 (30)
Ramaswami A. [23] India Retrospective Single-center 70 Apr 2021–Jun 2021 45 [38–56] 60 (42) 70 (49)
Gupta NK. [24] India Retrospective Single-center 74 Mar 2021–May 2021 52 65 (48) 97 (72)
Mishra Y. [25] India Retrospective Single-center 32 Apr 2021–May 2021 58 ± 9 47 (15) 88 (28)
Kumari A. [26] India Retrospective Single-center 20 Mar 2021–May 2021 54 [35–67] 55 (11) 80 (16)
Gupta DP. [27] India Prospective Single-center 70 Mar 2020–Dec 2020 [20–75] 67 (47) 100 (70)
Patel A. [28] India Retrospective Multi-center 187 Sep 2020–Dec 2020 57 ± 13 80 (150) 60 (113)
Dubey S. [29] India Retrospective Single-center 46 Apr 2021–Jun 2021 53 ± 10 64 (29) 100 (46)
Bhanuprasad K. [30] India Prospective Single-center 132 Jun 2020–Jul 2021 51 ± 12 77 (101) 98 (129)
Selarka L. [31] India Prospective Multi-center 47 Jan 2021–Mar 2021 55 ± 13 75 (35) 77 (36)
Muthu V. [32] India Retrospective Single-center 31 53 [48–58] 76 (23) 75 (21)
Pakdel F. [33] Iran Cross-sectional Multi-center 15 Apr 2020–Sep 2020 52 [14–71] 66 (10) 87 (13)
Meawed TE. [34] India Cross-sectional Single-center, ICU 11 Oct 2020–Apr 2021
Zirpe K. [35] India Retrospective Single-center 84 Feb 2021–Jun 2021 49 ± 12 83 (70) 64 (54)
Pal P. [36] India Prospective Single-center 31 May 2021–Jun 2021 53 [20–78] 68 (21) 100 (31)
Pippal SK. [37] India Prospective Single-center 80 May 2021–Aug 2021 69 (55) 90 (72)
Ismaiel WF. [38] Egypt Retrospective Single-center 10
Avatef Fazeli M. [39] Iran Retrospective Single-center 9 Oct 2020–Nov 2020 59 33 (3) 78 (7)
Goddanti N. [40] India Retrospective Single-center 300 Apr 2021–Jun 2021 49 ± 12 74 (222) 96 (287)
Kulkarni R. [41] India Retrospective Multi-center 49 Dec 2020–Jun 2021 53 ± 11 71 (35) 82 (40)
Dokania V. [42] India Prospective Single-center 21 Apr 2021–Jun 2021 50 ± 14 71 (15) 90 (19)
Nair AG. [43] India Retrospective Multi-center 13 36 [20–51] 69 (9) 0 (0)
Kumar S. [44] India Retrospective Single-center 287 May 2021–Jul 2021 79 (227) 80 (229)
Joshi AR. [45] India Retrospective Single-center 25 Mar 2021–Apr 2021 55 ± 13 88 (22)
Choksi T. [46] India Retrospective Single-center 73 Mar 2021–May 2021 54 ± 13 66 (48) 74 (48)
Bansai SB. [47] India Retrospective Single-center 11 Feb 2020–May 2021 47 ± 11 100 (11) 64 (7)
Fouad YA. [48] Egypt Retrospective Single-center 26 Apr 2021–Aug 2021 63 [46–70] 54 (14) 96 (25)
Meher R. [49] Iran Prospective Single-center 111 May 2021–Jun 2021 53 ± 12 70 (78) 94 (104)
Guzman-Castro S. [50] UK Retrospective Single-center 6 May 2021 52 [45–57] 83 (5) 83 (5)
Kumar H. [51] India Retrospective Single-center 28 Apr 2021–May 2021 54 [48–59] 79 (22) 75 (21)
Yadav T. [52] India Retrospective Single-center 50 Dec 2020–Jun 2021 50 [28–70] 62 (31) 86 (43)
Meshram HS. [53] India Retrospective Multi-center 61 Nov 2020–Jul 2021 45 [38–54] 89 (54) 49 (30)
Popli H. [54] India Retrospective Single-center 23 Jul 2020–Jun 2021 48 ± 12 57 (13) 78 (18)
Patel DD. [55] India Cross-sectional Single-center 96 Mar 2021–May 2021 49 [21–76] 73 (70) 72 (69)
Sen M. [7] India Case series Single-center 5 Aug 2020–Dec 2020 58 100 (5) 100 (5)
Saidha PK. [9] India Case series Single-center 6 [29–68] 66 (4) 100 (5)
Roushdy T. [56] Egypt Case series Single-center 2 Jan 2021–Apr 2021 [59–73] 100 (2) 100 (2)
Sai Krishna D. [57] India Case series Single-center 2 [34–50] 100 (2) 100 (2)
Nehara HR. [58] India Case series Single-center 5 [33–70] 20 (1) 100 (5)
Singh Y. [59] India Case series Single-center 13 Nov 2020–Jan 2021 [5–75] 85 (11) 62 (8)
Garg R. [60] India Case series Single-center 7 May 2021 [38–70] 71 (5) 100 (7)
Arana C. [61] Spain Case series Single-center 2 [48–62] 100 (2) 50 (1)
Barman Roy D. [62] India Case series Single-center 2 [39–50] 50 (1) 50 (1)
Ashour MM. [63] Egypt Case series Single-center 6 [41–67] 50 (3) 100 (6)
Pal P. [64] India Case series Single-center 10 May 2021–Jun 2021 [28–66] 60 (6) 70 (7)
Riad A. [65] Czech Case series Multi-center 6 Apr 2021–May 2021 [47–68] 71 (5) 83 (5)
Said Ahmed WM. [66] Egypt Case series Single-center 14 [29–77] 71 (10) 100 (14)
Alloush TK. [67] Egypt Case series Single-center 14 May 2021–Jun 2021 [49–82] 64 (9) 93 (!3)
Seidel D. [68] Germany Case series Multi-center 13 Feb 2020–Jun 2021 [30–75] 62 (8) 23 (3)
Author HTN, % (N) CKD, % (N) Immunosuppression, % (N) Malignancy, % (N) Hypoxia, % (N) Mechanical ventilation, % (N) Corticosteroids treatment, % (N) ICU admission, % (N)
Moorthy A. [20] 88 (15)
El-Kholy NA. [21]
Ravani SA. [22] 53 (17) 6.3 (2) 100 (19)
Ramaswami A. [23] 24 (17) 8.6 (6) 2.9 (2) 70 (49)
Gupta NK. [24] 6.8 (5) 1.4 (1) 69 (51) 91 (67)
Mishra Y. [25] 50 (16) 0 (0) 69 (22) 94 (30)
Kumari A. [26] 15 (3) 80 (16)
Gupta DP. [27] 7.1 (5) 2.9 (2)
Patel A. [28] 1.6 (3) 1.1 (2) 56 (74) 78 (146) 31 (58)
Dubey S. [29] 72 (33) 0 (0) 52 (24)
Bhanuprasad K. [30] 5.3 (7) 1.5 (2) 14 (19) 2.3 (3) 55 (73)
Selarka L. [31] 81 (38) 43 (20) 100 (47)
Muthu V. [32] 32 (9) 55 (16) 24 (7) 71 (20)
Pakdel F. [33] 47 (7) 13 (2) 60 (9) 6.7 (1) 47 (7)
Meawed TE. [34]
Zirpe K. [35] 37 (31) 3.6 (3) 68 (57) 83 (70)
Pal P. [36]
Pippal SK. [37] 75 (60) 1.3 (1)
Ismaiel WF. [38]
Avatef Fazeli M. [39] 44 (4) 22 (2) 11 (1) 13 (1) 100 (7) 25 (2)
Goddanti N. [40] 60 (180) 79 (237)
Kulkarni R. [41] 37 (18)
Dokania V. [42] 0.5 (1) 4.8 (1) 90 (19) 19 (4)
Nair AG. [43] 38 (5) 54 (7)
Kumar S. [44] 90 (257) 23 (66)
Joshi AR. [45] 8.0 (2) 100 (25) 48 (12) 100 (25) 100 (25)
Choksi T. [46] 82 (60) 4.1 (3) 98 (58)
Bansai SB. [47] 45 (5) 100 (11) 100 (11) 36 (4) 0 (0) 36 (4)
Fouad YA. [48] 27 (7) 12 (3) 77 (20)
Meher R. [49] 27 (30) 5.4 (6) 60 (67) 5.4 (6)
Guzman-Castro S. [50] 50 (3) 33 (2) 100 (6)
Kumar H. [51] 57 (16) 21 (6) 68 (19)
Yadav T. [52] 2.0 (1) 38 (19) 44 (22)
Meshram HS. [53] 100 (61) 100 (61) 67 (41) 0 (0) 44 (27)
Popli H. [54]
Patel DD. [55] 40 (38) 2.1 (2) 73 (70) 6.3 (6) 82 (79)
Sen M. [7] 80 (4)
Saidha PK. [9] 17 (1)
Roushdy T. [56] 100 (2) 50 (1)
Sai Krishna D. [57] 50 (1)
Nehara HR. [58] 40 (2) 20 (1) 40 (2)
Singh Y. [59] 46 (6) 15 (2) 23 (3) 85 (11) 69 (9) 77 (10) 77 (10)
Garg R. [60] 29 (2) 0 (0) 100 (7) 0 (0)
Arana C. [61] 100 (2) 100 (2) 100 (2) 100 (2) 0 (0) 100 (2) 50 (1)
Barman Roy D. [62] 0 (0) 0(0) 50 (1)
Ashour MM. [63] 17 (1)
Pal P. [64] 10 (1) 30 (3) 80 (8)
Riad A. [65] 17 (1) 50 (3) 100 (6)
Said Ahmed WM. [66] 21 (3)
Alloush TK. [67] 43 (6) 14 (2) 100 (14) 0 (0) 93 (13)
Seidel D. [68] 7.7 (1) 38 (5) 79 (11) 79 (11) 79 (11)

Value is shown as mean ± SD or median [range]. The columns of hypoxia, mechanical ventilation, corticosteroids treatment, and ICU admission was the data regarding COVID-19 severity and management. Abbreviations: SD, Standard deviation; HTN, Hypertension; CKD, Chronic kidney disease; ICU, Intensive care units;